About Hera Biotech
Hera Biotech is a private company based in San Antonio, Texas. It has reported $2,850,323 raised in four offerings on Form D since November 2020. Its chief executive is Somer Baburek.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 11, 2025 | Sep 23, 2025amended Sep 23, 2026 | $1,736,823of $5.0M target | 26 | $66,801 | Debt, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 2, 2024 | Aug 12, 2024 | $0of $6.0M target | 0 | — | Equity, OptionsRule 506(b) | Form D ↗ |
| May 18, 2023 | May 31, 2023 | $260,000of $1.0M target | 4 | $65,000 | Debt convertible into equity.Rule 506(b) | Form D ↗ |
| Nov 3, 2020 | Nov 10, 2020amended Feb 15, 2022 | $853,500of $2.0M target | 19 | $44,921 | Debt convertible into equity.Rule 506(b) | Form D/A ↗2 earlier filings |
| Total, four offerings | $2,850,323 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Hera Biotech's Form D filed Sep 23, 2026.
